Save on Ozempic: Generic Swaps Arrive in Canada
Generic Ozempic has arrived in Canada, slashing costs by two-thirds. Learn how this historic price drop benefits your health and wallet.
Health Canada Approves Ozempic to Reduce Heart Attack and Stroke Risk
Health Canada expands Ozempic approval to include reducing the risk of heart attacks and strokes in adults with type 2 diabetes and heart or kidney disease.
New Study Warns of Rapid Weight Regain When Quitting Weight Loss Drugs
New research shows stopping weight loss medication leads to rapid regain, with many returning to their original weight in less than two years.
Health Canada Authorizes First GLP-1 Pill to Reduce Heart Attack and Stroke Risk
Health Canada authorizes RYBELSUS® as the first oral GLP-1 to reduce heart attack and stroke risk in adults with type 2 diabetes.
Generic Ozempic: Canada to See Significant Price Drops
Struggling with high medication costs? Generic Ozempic is coming to Canada in 2026. Learn how prices could drop from $400 to around $100.
Wegovy Authorized as Canada’s First Liver Disease Drug
No more "watchful waiting." Health Canada’s approval of Wegovy gives MASH patients their first tangible medical option to fight liver fibrosis.
Think You Know Diabetes? Half of Canadians Still Believe the Myths
From “too much sugar” myths to unfair blame, Diabetes Canada is calling on Canadians to stop the stigma and learn the facts.
Empower and Inform Your Menopause Journey: Expert Interview with Amanda Thebe
Author, nutritionist, and women’s health advocate Amanda Thebe shares insights on hormone therapy, nutrition, strength training, and lifestyle strategies — showing why understanding your body is the most powerful tool for thriving through midlife.
Ozempic, Wegovy Lawsuits Raise Alarms Over Rare Vision Loss Risk
U.S. lawsuits link Ozempic and similar drugs to rare vision loss. Learn the risks of semaglutide medications and what Canadians should watch for.
Ozempic Now Approved to Treat Kidney Disease in Patients with Type 2 Diabetes
A major international study called The FLOW trial has resulted in approval for Ozempic from Health Canada to help treat CKD in people with type 2 diabetes.
Ashwagandha 101: The Adaptogen Everyone’s Popping—Should You Join the Hype?
Ashwagandha is everywhere right now. From stress relief to sex drive—see which claims check out, and which should raise red flags.
Weight-Loss Med Wegovy Now Approved to Treat Heart Attack Risk
Discover how the medication Wegovy tackles obesity and reduces heart attack risk by 20% - a breakthrough for many Canadians.